CELLPLY SRL -  

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 1
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 2.331.266 259.438 1
2018 2.343.950 0 2.343.950 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CROMED KUTATO ES SZOLGALTATO KOZPONTOK KFT1
DEHNE MATTHIAS1
DRESDEN UNIVERSITY OF TECHNOLOGY1
EUROPEAN CANCER PATIENT COALITION1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FOX BIOSYSTEMS NV1
HELMHOLTZZENTRUM DRESDENROSSENDORF EV1
HISTOGENEX NV1
INSEL GRUPPE1
JOHANNES GUTENBERG UNIVERSITAET MAINZ1
QUINTESSENCE CONSULTING1
SCV1
SEMMELWEIS UNIVERSITY OF MEDICINE1
UNIVERSIDAD AUTONOMA DE MADRID1
UNIVERSITAET BERN1
UNIVERSITEIT ANTWERPEN1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF COPENHAGEN1

Constancy:

Total number of partners: 19
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 19
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Protease‐guided tumor targeting tools to revolutionize cancer diagnosis and treatment. OncoProToolsparticipant2.331.26620
2018-09-01ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics ONCOSMARTcoordinator2.343.9501